Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells

Search this Article

Author(s)

    • ARAKI Norie
    • Department of Tumor Genetics and Biology, Graduate School of Medical Sciences, Kumamoto University School of Medicine
    • KUNIYASU Akihiko
    • Department of Molecular Cell Function, Graduate School of Pharmaceutical Sciences, Kumamoto University
    • KAWAGUCHI Tatsuya
    • Department of Hematology and Infectious Diseases, Kumamoto University Hospital

Journal

  • Cancer science

    Cancer science 101(1), 137-142, 2010-01-10

References:  36

Codes

  • NII Article ID (NAID)
    10027199844
  • NII NACSIS-CAT ID (NCID)
    AA11808050
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    13479032
  • Data Source
    CJP 
Page Top